SCHEMBL7223605

SCHEMBL7223605

CCCCNCC(O)COc1ccc(C(c2ccc(OC)cc2)C2CCCc3ccccc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 6/20 0.46
ADRB2 P07550 5/20 0.46
ADRB1 P08588 5/20 0.46
ALDH1A1 P00352 4/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
TP53 P04637 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43
UGCG Q16739 1/20 0.43
LMNA P02545 1/20 0.43
KDM4E B2RXH2 2/20 0.42
CASR P41180 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7224992 0.91 ADRB3 (0.42) ADRB3ADRB2ADRB1ALDH1A1HTT
SCHEMBL7220715 0.85 KDM4E (0.48) ALDH1A1HTTKMT2AMEN1UGCG
SCHEMBL13719534 0.78 ADRB3 (0.68) ADRB3ADRB2ADRB1ALDH1A1HTT
SCHEMBL7221545 0.76 ALDH1A1 (0.46) ALDH1A1HTTKMT2AMEN1UGCG
SCHEMBL7220749 0.74 PKM (0.46) ALDH1A1HTTKMT2AMEN1TP53
SCHEMBL7223322 0.73 PSMB1 (0.52) ALDH1A1KMT2AMEN1UGCG
SCHEMBL11748513 0.73 UGCG (0.44) ALDH1A1HTTKMT2AMEN1UGCG
Hydrochloric Acid SCHEMBL7223567 0.72 PSMB1 (0.51) ALDH1A1KMT2AMEN1UGCG
SCHEMBL7223883 0.72 PSMB1 (0.54) ALDH1A1KMT2AMEN1UGCG
SCHEMBL7223982 0.71 MAPT (0.50) ADRB3ADRB2ADRB1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6610705-B1 Treating breast cancer, osteoporosis, hypercholesteremia or endometriosis COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2003-08-26 US claimed
US-6610705-B1 Treating breast cancer, osteoporosis, hypercholesteremia or endometriosis COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2003-08-26 US disclosed